Daiichi Sankyo seeks marketing approval for mRNA Covid-19 vaccine DS-5670 in Japan
DS-5670 is an mRNA vaccine being developed against the novel coronavirus infectious disease (COVID-19). It is proposed to be used as a booster vaccine to prevent Covid-19. The